Canton Strategic Inc
CNTN | NASDAQ
$1.95
-$0.10 (-4.88%)
At close: Oct 30, 2026, 3:59 PM ET
$1.95
$0.00 (+0.05%)
Pre-market:
Nov 2, 2026, 4:11 AM ET
-4.88%
(1D)No price chart data available for 1D timeframe.
Rating
49.2
+3.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #289/1028 (Top 28%)
Key Statistics
Market Data
Market Cap $154.98M
1D Range
1.93 2.05
52W Range
1.69 5.48
Valuation (TTM)
PE -1.24
PB 0.34
EV/EBITDA -1.34
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Cash Flow
FCF Yield -14.3%
SBC Adj. FCF Yield -35.5%
SBC Impact -148.2%
Margins
Gross Margin 100.0%
Operating Margin -3595.2%
FCF Margin -1482.1%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 125.3% |
54.9%
FCF 3Y | 5Y -56.8% |
-36.0%
Returns
ROA -17.4%
ROE -29.5%
ROIC -8.1%
Financial Health
Net Cash
$37.24M
Current Ratio 15.70
Interest Coverage -3,921.73
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institution...
Sector Healthcare
Industry Biotechnology
Employees 12
IPO Date Jan 12, 2022
Website www.cantonstrategic.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CNTN